Compare IBEX & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IBEX | ANGO |
|---|---|---|
| Founded | 2017 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 383.7M | 420.2M |
| IPO Year | 2017 | 2004 |
| Metric | IBEX | ANGO |
|---|---|---|
| Price | $28.46 | $10.47 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $35.00 | $18.00 |
| AVG Volume (30 Days) | 109.2K | ★ 472.7K |
| Earning Date | 05-07-2026 | 04-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 28.26 | ★ 81.92 |
| EPS | ★ 1.65 | N/A |
| Revenue | ★ $558,273,000.00 | $291,010,000.00 |
| Revenue This Year | $14.13 | $9.11 |
| Revenue Next Year | $5.68 | $4.94 |
| P/E Ratio | $17.25 | ★ N/A |
| Revenue Growth | 9.77 | ★ 10.17 |
| 52 Week Low | $22.63 | $8.36 |
| 52 Week High | $42.99 | $13.99 |
| Indicator | IBEX | ANGO |
|---|---|---|
| Relative Strength Index (RSI) | 51.13 | 48.66 |
| Support Level | $28.26 | $10.38 |
| Resistance Level | $30.55 | $11.25 |
| Average True Range (ATR) | 0.87 | 0.60 |
| MACD | 0.28 | -0.05 |
| Stochastic Oscillator | 85.33 | 42.50 |
IBEX Ltd delivers innovative business process outsourcing (BPO), smart digital marketing, online acquisition technology, and end-to-end customer engagement solutions to help companies acquire, engage, and retain valuable customers. It is an end-to-end provider of technology-enabled customer lifecycle experience (CLX) solutions to optimize customer acquisition, engagement, expansion, and experience for its clients. IBEX operates through the Business process outsourcing segment. Its services cover three areas: Digital and omni-channel Customer Experience (ibex Connect), Digital Marketing and E-Commerce (ibex Digital) and Digital CX surveys and analytics (ibex CX). It caters to a broad range of industries, such as telecommunications, cable, financial services, and healthcare.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.